WhaleCreep
HomeFundsSabby Management, LLC › Q2 2026

Sabby Management, LLC 13F holdings, Q2 2026

Holdings as of June 30, 2026 · filings on SEC EDGAR · this is the latest filing on record

Sabby Management, LLC disclosed 16 US equity positions worth $12.0m in its Q2 2026 13F filing. The largest position was SPY at 34.2% of the reported book, followed by TOYO CO LTD and FARMMI INC. Against the Q1 2026 filing, it opened 8 new positions, added to 4 and reduced 4 among the top 16 holdings.

← Q1 2026

What did Sabby Management, LLC own in Q2 2026? Top 16 positions

#StockSectorWeightValueSharesΔ sharesvs Q1 2026
1 SPY STATE STREET SPDR S&P 34.2%$4.1m5,500 101% added
2 TOYO CO LTD 29.1%$3.5m503,846 new
3 FARMMI INC 7.0%$840.3k3,515,929 new
4 CRVO CERVOMED INC 6.4%$771.5k248,880 new
5 TEMPEST THERAPEUTICS INC 4.7%$567.5k511,286 2763% added
6 PARANOVUS ENTERTNMNT TECH LT 4.7%$560.5k75,440 new
7 BIOAFFINITY TECHNOLOGIES 2.5%$296.9k365,647 new
8 SMART POWER CORP 2.2%$263.2k127,774 new
9 BRIACELL THERAPEUTICS CORP 2.2%$261.5k80,721 9% added
10 REVELATION BIOSCIENCES INC 1.8%$216.9k210,582 112% added
11 SNES SENESTECH INC 1.8%$211.2k141,756 -35% reduced
12 BRIACELL THERAPEUTICS CORP 1.4%$169.4k190,383 -50% reduced
13 SIDU SIDUS SPACE INC 1.0%$121.9k43,377 new
14 INM INMED PHARMACEUTICALS 0.6%$69.7k44,970 -80% reduced
15 NUWELLIS INC 0.4%$49.9k16,372 new
16 BRIACELL THERAPEUTICS CORP 0.1%$11.5k120,802 -42% reduced

Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.